Effects of the rapid-acting insulin analogue Insulin Aspart on postprandial glycaemic excursions in type 2 diabetes

被引:0
|
作者
Thorsby, P
Rosenfalck, AM
Kjems, L
Hanssen, KF
Madsbad, S
Birkeland, KI
机构
[1] Aker Univ Hosp, Oslo, Norway
[2] Univ Copenhagen, Hvidovre Hosp, DK-2650 Hvidovre, Denmark
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
57
引用
收藏
页码:A17 / A17
页数:1
相关论文
共 50 条
  • [21] Variability of the metabolic effect of soluble insulin and the rapid-acting insulin analog insulin aspart
    Heinemann, L
    Weyer, C
    Rauhaus, M
    Heinrichs, S
    Heise, T
    DIABETES CARE, 1998, 21 (11) : 1910 - 1914
  • [22] Double-blind mealtime faster-acting insulin aspart improves glycaemic control with superior reduction in postprandial glucose excursions vs insulin aspart in type 1 diabetes: onset® 1
    Russell-Jones, D.
    Bode, B. W.
    De Block, C.
    Franek, E.
    Heller, S.
    Mathieu, C.
    Philis-Tsimikas, A.
    Rose, L.
    Woo, V.
    Osterskov, A. B.
    Graungaard, T.
    Bergenstal, R. M.
    DIABETOLOGIA, 2016, 59 : S6 - S6
  • [23] Pharmacokinetics of the rapid-acting insulin analog, insulin aspart, in rats, dogs, and pigs, and pharmacodynamics of insulin aspart in pigs
    Plum, A
    Agerso, H
    Andersen, L
    DRUG METABOLISM AND DISPOSITION, 2000, 28 (02) : 155 - 160
  • [24] Pharmacokinetics of the rapid-acting insulin analog, insulin aspart, is independent of hepatic function
    Lyness, W
    Tyler, J
    Lawrence, A
    DIABETES, 2001, 50 : A442 - A442
  • [25] Rapid-acting insulin approved for type 1 and type 2 diabetes mellitus
    不详
    NURSE PRACTITIONER, 2020, 45 (11): : 56 - 56
  • [26] Efficacy and safety comparison of rapid-acting insulin aspart and regular human insulin in the treatment of type 1 and type 2 diabetes mellitus: A systematic review
    Rys, P.
    Pankiewicz, O.
    Lach, K.
    Kwaskowski, A.
    Skrzekowska-Baran, I.
    Malecki, M. T.
    DIABETES & METABOLISM, 2011, 37 (03) : 190 - 200
  • [27] Premeal injection of rapid acting insulin reduces postprandial glycaemic excursions, a randomised controlled trial
    Luijf, Y. M.
    van Bon, A. C.
    Hoekstra, J. B. L.
    DeVries, J. H.
    DIABETOLOGIA, 2010, 53
  • [28] The effect of the optimal use of rapid-acting insulin analogues on insulin secretion in Type 2 diabetes
    Gallagher, A.
    Butler, T. J.
    Home, P. D.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 76 (03) : 327 - 334
  • [29] Addition of rapid-acting insulin to basal insulin therapy in type 2 diabetes: indications and modalities
    Monnier, L
    Colette, C
    DIABETES & METABOLISM, 2006, 32 (01) : 7 - 13
  • [30] Glycemic Effects of Once-a-Day Rapid-Acting Insulin Analogue Addition on a Basal Insulin Analogue in Korean Subjects with Poorly Controlled Type 2 Diabetes Mellitus
    Choe, Eun Yeong
    Lee, Yong-Ho
    Lee, Byung-Wan
    Kang, Eun-Seok
    Cha, Bong Soo
    Lee, Hyun Chul
    DIABETES & METABOLISM JOURNAL, 2012, 36 (03) : 230 - 236